359 related articles for article (PubMed ID: 34258311)
1. Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
Nicholson S; Karapanagiotidis T; Khvorov A; Douros C; Mordant F; Bond K; Druce J; Williamson DA; Purcell D; Lewin SR; Sullivan S; Subbarao K; Catton M
Open Forum Infect Dis; 2021 Jul; 8(7):ofab239. PubMed ID: 34258311
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.
Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC
Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714
[TBL] [Abstract][Full Text] [Related]
3. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 antibody response dynamics and heterogeneous diagnostic performance of four serological tests and a neutralization test in symptomatic healthcare workers with non-severe COVID-19.
Ong DSY; Keuren F; van der Vliet M; Boxma-de Klerk BM; Koeleman JGM
J Clin Virol; 2021 Aug; 141():104904. PubMed ID: 34229209
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples.
Hanssen DAT; Slaats M; Mulder M; Savelkoul PHM; van Loo IHM
Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1695-1703. PubMed ID: 33733395
[TBL] [Abstract][Full Text] [Related]
7. Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use.
Nilsson AC; Holm DK; Justesen US; Gorm-Jensen T; Andersen NS; Øvrehus A; Johansen IS; Michelsen J; Sprogøe U; Lillevang ST
Int J Infect Dis; 2021 Feb; 103():381-388. PubMed ID: 33310021
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test.
Bal A; Pozzetto B; Trabaud MA; Escuret V; Rabilloud M; Langlois-Jacques C; Paul A; Guibert N; D'Aubarède-Frieh C; Massardier-Pilonchery A; Fabien N; Goncalves D; Boibieux A; Morfin-Sherpa F; Pitiot V; Gueyffier F; Lina B; Fassier JB; Trouillet-Assant S;
Clin Chem; 2021 Apr; 67(5):742-752. PubMed ID: 33399823
[TBL] [Abstract][Full Text] [Related]
9. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features.
Rowntree LC; Chua BY; Nicholson S; Koutsakos M; Hensen L; Douros C; Selva K; Mordant FL; Wong CY; Habel JR; Zhang W; Jia X; Allen L; Doolan DL; Jackson DC; Wheatley AK; Kent SJ; Amanat F; Krammer F; Subbarao K; Cheng AC; Chung AW; Catton M; Nguyen TH; van de Sandt CE; Kedzierska K
Clin Transl Immunology; 2021; 10(3):e1258. PubMed ID: 33680466
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
[TBL] [Abstract][Full Text] [Related]
11. Humoral Immune Response to SARS-CoV-2.
Herroelen PH; Martens GA; De Smet D; Swaerts K; Decavele AS
Am J Clin Pathol; 2020 Oct; 154(5):610-619. PubMed ID: 32808976
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories.
Harritshøj LH; Gybel-Brask M; Afzal S; Kamstrup PR; Jørgensen CS; Thomsen MK; Hilsted L; Friis-Hansen L; Szecsi PB; Pedersen L; Nielsen L; Hansen CB; Garred P; Korsholm TL; Mikkelsen S; Nielsen KO; Møller BK; Hansen AT; Iversen KK; Nielsen PB; Hasselbalch RB; Fogh K; Norsk JB; Kristensen JH; Schønning K; Kirkby NS; Nielsen ACY; Landsy LH; Loftager M; Holm DK; Nilsson AC; Sækmose SG; Grum-Schwensen B; Aagaard B; Jensen TG; Nielsen DM; Ullum H; Dessau RB
J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33574119
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
[TBL] [Abstract][Full Text] [Related]
14. Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies.
Lokida D; Karyana M; Kosasih H; Mardian Y; Sugiyono RI; Arlinda D; Lukman N; Salim G; Butar Butar DP; Naysilla AM; Irmansyah
Heliyon; 2022 Dec; 8(12):e12614. PubMed ID: 36575657
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
Zedan HT; Yassine HM; Al-Sadeq DW; Liu N; Qotba H; Nicolai E; Pieri M; Bernardini S; Abu-Raddad LJ; Nasrallah GK
Sci Rep; 2022 Nov; 12(1):19020. PubMed ID: 36347859
[TBL] [Abstract][Full Text] [Related]
16. SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.
Walker GJ; Naing Z; Ospina Stella A; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557418
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test.
Embregts CWE; Verstrepen B; Langermans JAM; Böszörményi KP; Sikkema RS; de Vries RD; Hoffmann D; Wernike K; Smit LAM; Zhao S; Rockx B; Koopmans MPG; Haagmans BL; Kuiken T; GeurtsvanKessel CH
One Health; 2021 Dec; 13():100313. PubMed ID: 34458548
[TBL] [Abstract][Full Text] [Related]
18. Detection of IgM, IgG, IgA and neutralizing antibody responses to SARS-CoV-2 infection and mRNA vaccination.
Fleischmann CJ; Bulman CA; Yun C; Lynch KL; Wu AHB; Whitman JD
J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748419
[No Abstract] [Full Text] [Related]
19. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
[TBL] [Abstract][Full Text] [Related]
20. Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays.
Ismail A; Shurrab FM; Al-Jighefee HT; Al-Sadeq DW; Qotba H; Al-Shaar IA; Yassine HM; Abu-Raddad LJ; Nasrallah GK
Front Biosci (Landmark Ed); 2021 Jul; 26(7):198-206. PubMed ID: 34340267
[No Abstract] [Full Text] [Related]
[Next] [New Search]
